| Literature DB >> 27873504 |
Kijeong Lee1, Eun Hye Kim1, Dongbeom Song1, Young Dae Kim1, Hyo Suk Nam1, Hye Sun Lee2, Ji Hoe Heo3.
Abstract
PURPOSE: Patients with superficial middle cerebral artery (MCA) territory infarction may have concomitant lenticulostriate artery (LSA) territory infarction. We investigated the mechanisms thereof and the outcomes of patients with superficial MCA territory infarction according to the presence or absence of LSA involvement.Entities:
Keywords: Lenticulostriate artery; cerebral infarction; middle cerebral artery; mortality; prognosis
Mesh:
Year: 2017 PMID: 27873504 PMCID: PMC5122627 DOI: 10.3349/ymj.2017.58.1.123
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Comparison of Baseline Characteristics
| SM (n=314) | SM+L (n=84) | ||
|---|---|---|---|
| Age, yr | 66.5±11.4 | 68.6±13.0 | 0.148 |
| Sex, men | 219 (69.7) | 54 (64.3) | 0.338 |
| Hypertension | 222 (70.7) | 60 (71.4) | 0.896 |
| Diabetes | 136 (43.3) | 34 (40.5) | 0.641 |
| Hypercholesterolemia | 45 (14.3) | 8 (9.5) | 0.249 |
| Current smoking | 82 (26.1) | 17 (20.2) | 0.268 |
| Coronary heart disease | 74 (23.6) | 19 (22.6) | 0.855 |
| Previous medication | |||
| Antiplatelet | 116 (36.9) | 25 (29.8) | 0.222 |
| Anticoagulant | 23 (7.3) | 3 (3.6) | 0.216 |
| Statin | 68 (21.7) | 17 (20.2) | 0.778 |
| Antihypertensive | 138 (43.9) | 43 (51.2) | 0.236 |
| Diabetes medication | 25 (8.0) | 4 (4.8) | 0.316 |
| Initial NIHSS | 4.02±4.97 | 10.83±7.11 | <0.001 |
| Significant brain swelling | 10 (3.2) | 13 (15.5) | <0.001 |
| Laboratory results | |||
| Hemoglobin, g/dL | 13.9±2.1 | 14.2±1.8 | 0.157 |
| Hematocrit, % | 40.7±5.8 | 41.9±4.9 | 0.091 |
| White blood cells, K/mm3 | 8.0±2.8 | 9.1±3.2 | 0.005 |
| Platelet, K/mm3 | 245.5±84.2 | 247.9±73.6 | 0.818 |
| Prothrombin time, INR | 1.0±0.3 | 1.0±0.2 | 0.848 |
| ESR, mm/H | 25.8±23.5 | 25.9±21.7 | 0.976 |
| hsCRP, mg/dL | 11.3±29.5 | 22.5±50.0 | 0.057 |
| Total cholesterol, mmol/L | 4.7±1.1 | 4.6±1.1 | 0.453 |
| LDL cholesterol, mmol/L | 2.7±0.9 | 2.8±0.9 | 0.181 |
| HDL cholesterol, mmol/L | 1.1±0.3 | 1.1±0.3 | 0.928 |
| Fasting sugar, mmol/L | 6.6±2.4 | 6.6±2.1 | 0.907 |
| Glycated hemoglobin, % | 6.6±1.4 | 6.6±1.3 | 0.685 |
SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery; NIHSS, National Institutes of Health Stroke Scale; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Data are number (%), mean±standard deviation.
Subtype and Stroke Mechanisms
| SM (n=314) | SM+L (n=84) | ||
|---|---|---|---|
| Stroke subtype | 0.003 | ||
| Large artery atherosclerosis* | 76 (24.2) | 31 (36.9) | |
| Cardioembolism | 109 (34.7) | 27 (32.1) | |
| Two or more causes* | 66 (21.0) | 22 (26.2) | |
| Negative evaluation | 63 (20.1) | 4 (4.8) | |
| Stroke mechanism | |||
| Significant MCA stenosis | 43 (13.7) | 33 (39.3) | <0.001 |
| Significant ICA stenosis | 45 (14.3) | 28 (33.3) | <0.001 |
| High-risk PCSE | 84 (26.8) | 35 (41.7) | 0.008 |
SM, superficial MCA only; SM+L, superficial MCA plus lenticulostriate artery; MCA, middle cerebral artery; ICA, internal carotid artery, PCSE, potential cardiac source of embolism.
Values are numbers (%).
*p<0.005; comparison with negative evaluation using Bonferroni post-hoc analysis.
Fig. 1Comparison of mean NIHSS scores for each item between the groups. Scores for all NIHSS items except that for limb ataxia are significantly higher in the SM+L group. NIHSS, National Institute of Health Stroke Scale; SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery; LOC, loss of consciousness.
Fig. 2Modified Rankin Scale at 3 months of symptom onset. Numbers are percentages (%). SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery.
Univariate Analysis of Factors Associated with a Poor Outcome at 3 Months
| Patient with favorable outcome (n=294) | Patient with poor outcome (n=104) | ||
|---|---|---|---|
| Age, yr | 65.1±11.6 | 72.0±10.6 | <0.001 |
| Sex, men | 210 (71.4) | 63 (60.6) | 0.040 |
| LSA involvement | 30 (10.2) | 54 (51.9) | <0.001 |
| Hypertension | 204 (69.4) | 78 (75.0) | 0.279 |
| Diabetes | 124 (42.3) | 46 (44.2) | 0.716 |
| Hypercholesterolemia | 41 (13.9) | 12 (11.5) | 0.535 |
| Current smoking | 83 (28.2) | 16 (15.4) | 0.009 |
| Coronary heart disease | 71 (24.1) | 22 (21.2) | 0.535 |
| Initial NIHSS | 3.11±3.73 | 12.10±6.76 | <0.001 |
| Significant brain swelling | 3 (1.0) | 20 (19.2) | <0.001 |
| Significant MCA stenosis | 37 (12.6) | 39 (37.5) | <0.001 |
| Significant ICA stenosis | 40 (13.6) | 33 (31.7) | <0.001 |
| High-risk PCSE | 71 (24.1) | 48 (46.2) | <0.001 |
| Laboratory results | |||
| Hemoglobin, g/dL | 13.9±2.0 | 13.8±2.2 | 0.315 |
| White blood cells, K/mm3 | 7.8±2.6 | 9.3±3.4 | <0.001 |
| Platelet, K/mm3 | 245.2±79.1 | 248.2±90.2 | 0.752 |
| Prothrombin time, INR | 1.0±0.3 | 1.0±0.2 | 0.827 |
| ESR, mm/H | 23.4±21.5 | 32.2±26.0 | 0.002 |
| hsCRP, mg/dL | 8.5±22.5 | 28.4±54.8 | 0.001 |
| Total cholesterol, mmol/L | 4.7±1.1 | 4.5±1.1 | 0.045 |
| LDL cholesterol, mmol/L | 2.7±0.8 | 2.8±1.0 | 0.575 |
| HDL cholesterol, mmol/L | 1.1±0.3 | 1.1±0.3 | 0.174 |
| Fasting sugar, mmol/L | 6.4±2.4 | 6.9±2.4 | 0.121 |
| Glycated hemoglobin, % | 6.6±1.4 | 6.6±1.3 | 0.971 |
LSA, lenticulostriate artery; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebra artery; ICA, internal carotid artery; PCSE, potential cardiac source of embolism; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Data are number (%), mean±standard deviation.
Multivariate Analysis of Factors Associated with a Poor Outcome at 3 Months
| Adjusted odds ratio | 95% CI | ||
|---|---|---|---|
| Age, per increment of 10 | 2.048 | 1.422–2.952 | <0.001 |
| Sex, men | 0.700 | 0.335–1.463 | 0.343 |
| Initial NIHSS score | 1.203 | 1.129–1.292 | <0.001 |
| Superficial MCA territorial infarction volume, per increment of 1 cm3 | 1.016 | 1.002–1.032 | 0.031 |
| Significant brain swelling | 4.903 | 0.743–32.362 | 0.099 |
| Significant MCA stenosis | 2.868 | 1.209–6.806 | 0.017 |
| Significant ICA stenosis | 3.707 | 1.617–8.498 | 0.002 |
| High-risk PCSE | 1.514 | 0.702–3.264 | 0.290 |
| White blood cells, per increment of 1000 | 1.105 | 0.981–1.244 | 0.101 |
| Involvement of LSA territory | 3.686 | 1.693–8.027 | 0.001 |
NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery; PCSE, potential cardiac source of embolism; LSA, lenticulostriate artery; CI, confidence interval.
Fig. 3Kaplan-Meier curve for all-cause mortality (A) and stroke mortality (B). SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery.
Cox Regression Model of Stroke Mortality in Multivariate Analysis
| Model 2 | Model 2 | |||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Age, yr, per increment of 10 | 2.114 (1.300–3.537) | 0.003 | 1.983 (1.193–3.297) | 0.008 |
| Sex, men | 3.231 (0.946–11.042) | 0.061 | 2.009 (0.632–6.383) | 0.237 |
| Involvement of LSA territory | 3.652 (1.071–12.454) | 0.038 | 4.230 (1.394–12.838) | 0.011 |
| Erythrocyte sedimentation rate | 1.008 (0.998–1.028) | 0.431 | ||
| Initial NIHSS score | 1.117 (1.020–1.222) | 0.016 | ||
| Superficial MCA territorial infarction volume, per increment of 1 cm3 | 1.000 (0.990–1.011) | 0.958 | ||
| Significant brain swelling | 3.302 (1.094–9.961) | 0.034 | ||
| Significant MCA stenosis | 3.176 (1.069–9.441) | 0.038 | ||
| Significant ICA stenosis | 3.108 (0.992–9.742) | 0.052 | ||
LSA, lenticulostriate artery; NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery.
Model 1 includes age, sex, erythrocyte sedimentation rate, initial NIHSS, superficial territorial infarction volume and involvement of LSA and model 2 includes age, sex, significant brain swelling, significant MCA stenosis, significant ICA stenosis and involvement of LSA.